Screening annually with a method like OC-Auto FIT improves outcomes and delivers greater cost-effectiveness. Key findings from the study include: Annual FIT-based screening produced fewer CRC cases, ...

CORTLANDT MANOR, N.Y., April 11 Polymedco, Inc. is pleasedto announce the introduction of the PATHFAST immunoassay analyzer. ThePATHFAST rapid point of care system utilizes a chemiluminescent ...

Helen Landicho, Senior Vice President of Regulatory Affairs has exuberantly stated, "I truly believe that because of the efforts by the Southeastern Colorectal Cancer Coalition, the Symposium will be ...

CORTLANDT MANOR, N.Y., Jan. 30, 2024 /PRNewswire/ -- Polymedco, a leading provider of best-in-class colorectal cancer screening and early detection solutions, is proud to announce its membership in ...

SANTA BARBARA, CA / ACCESSWIRE / August 14, 2015 / As health plans and accountable care organizations (ACOs) across the United States review their colorectal cancer (CRC) screening practices, many of ...

Polymedco, a manufacturer, marketer and distributor in the clinical laboratory space, has pledged support to the Colon Cancer Prevention Project, based in Louisville, Ky. Polymedco will lend support ...

* Announced that Polymedco, Inc., leading provider of colorectal cancer tests in North America, reiterates its commitment to support Epi proColon in United States * Polymedco is continuing to ...

LAKE FOREST, Ill., June 6, 2022 /PRNewswire/ -- RoundTable Healthcare Partners ("RoundTable"), an operating-oriented private equity firm focused exclusively on the healthcare industry, announced today ...

Phenomenome Discoveries Inc. and Polymedco Cancer Diagnostic Products LLC. have announced a commercial licensing agreement for the US market, providing rights to Polymedco to commercialize PDI’s ...

Epigenomics AG has announced that Polymedco, Inc. reiterates its commitment to support Epi proColon(R) in the United States. Epi proColon(R) is Epigenomics' convenient blood-based test for colorectal ...

Annual FIT-based screening produced fewer CRC cases, fewer CRC deaths and more life years gained versus all other strategies, even at real-world adherence rates. Every screening strategy that was ...